Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Activation of mTOR signaling in adult lung microvascular progenitor cells accelerates lung aging
Emma C. Mason, … , Fabienne Gally, Susan M. Majka
Emma C. Mason, … , Fabienne Gally, Susan M. Majka
Published October 24, 2023
Citation Information: J Clin Invest. 2023;133(24):e171430. https://doi.org/10.1172/JCI171430.
View: Text | PDF
Research Article Vascular biology

Activation of mTOR signaling in adult lung microvascular progenitor cells accelerates lung aging

  • Text
  • PDF
Abstract

Reactivation and dysregulation of the mTOR signaling pathway are a hallmark of aging and chronic lung disease; however, the impact on microvascular progenitor cells (MVPCs), capillary angiostasis, and tissue homeostasis is unknown. While the existence of an adult lung vascular progenitor has long been hypothesized, these studies show that Abcg2 enriches for a population of angiogenic tissue-resident MVPCs present in both adult mouse and human lungs using functional, lineage, and transcriptomic analyses. These studies link human and mouse MVPC-specific mTORC1 activation to decreased stemness, angiogenic potential, and disruption of p53 and Wnt pathways, with consequent loss of alveolar-capillary structure and function. Following mTOR activation, these MVPCs adapt a unique transcriptome signature and emerge as a venous subpopulation in the angiodiverse microvascular endothelial subclusters. Thus, our findings support a significant role for mTOR in the maintenance of MVPC function and microvascular niche homeostasis as well as a cell-based mechanism driving loss of tissue structure underlying lung aging and the development of emphysema.

Authors

Emma C. Mason, Swapna Menon, Benjamin R. Schneider, Christa F. Gaskill, Maggie M. Dawson, Camille M. Moore, Laura Craig Armstrong, Okyong Cho, Bradley W. Richmond, Jonathan A. Kropski, James D. West, Patrick Geraghty, Brigitte N. Gomperts, Kevin C. Ess, Fabienne Gally, Susan M. Majka

×

Figure 5

Transcriptomic comparison of MVPCs isolated from WT, mTOR-activated, and mTOR-regulated cell lines identifies links between mTOR and p53 signaling pathways.

Options: View larger image (or click on image) Download as PowerPoint
Transcriptomic comparison of MVPCs isolated from WT, mTOR-activated, and...
CD45–GFP+ MVPCs were sorted from WT or Tsc2KD mouse lungs and cultured to establish primary cell lines from matched WT (2 cell lines), mTOR regulated (1 cell line), and mTOR+ (1 cell line). Each independent cell line was analyzed in triplicate using bulk RNA-Seq. (A) Heatmap comparisons of DEGs with an average normalized expression above 2 and a log2 fold change greater than 1 in either direction are represented. There are 224 significantly differentially expressed genes (KD vs. WT) in the mTOR+ comparison and 887 significantly differentially expressed genes (KD vs. WT) in the Tsc2-regulated comparison, log fold-change (lfc) ≥ 1. A Venn diagram of DEGs from mTOR-activated (mTOR+) MVPCs relative to mTOR-regulated (mTOR=) MVPCs is shown. (B) Functional interaction network of mTOR-regulated DEGs. The STRING database of protein-protein interactions was used to derive the interactions. The shapes of nodes in the network correspond to functions of pathways, while the colors are scaled to biological significance score (61) of the respective gene (log2 fold change × –log10 adjusted P value). Genes identified as unique regulators are gray. mTOR, gray; p53, red; Tsc2, yellow. All interactions shown here have STRING scores of 0.4 or above, representing medium confidence or higher in the evidence of interaction. (C) Dot plot of Reactome functional categories that were significantly enriched in the mTOR-activated DEGs list versus regulated MVPCs generated using the CompareCluster function from the Bioconductor package ClusterProfiler (102). The size of the dots corresponds to the gene ratio, the number of genes in the list annotated to the given Reactome category divided by the total number of DEGs with unique Entrez identifiers in the list. The color scale represents the adjusted P values obtained for enrichment of the category in each gene list.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts